Findings from Spherix Global Insights’ research reveal nearly three-quarters anticipate frontline use, with significant ...

I've been diagnosed with myeloma . What can I expect going forward? ANSWER: Myeloma is a cancer that affects specialized antibody-producing cells called plasma c ...

BCMA CAR T approvals (ide-cel 2021; cilta-cel 2022) deliver near-98% response in trials but require specialized centers, creating logistical constraints on access. Across >9 million UC patients, ...

Clinical trial led by UAB researcher supports approval of new, potentially curative treatment for multiple myeloma ...

This Multiple Myeloma Awareness Month, Dr Brid Seoighe, medical director at Johnson & Johnson Innovative Medicine Ireland, ...

In a recent discussion with CURE, Wrice noted that a "fear of talking to doctors" often prevents patients from sharing their full experience. She observed that younger patients, in particular, may ...

Survival in myeloma is clearly being prolonged,” says Mikhael. “Whereas historically, we saw a greater impact in younger ...

A “significant number of patients” could see a cure for multiple myeloma within the next two decades, one expert told ...

Multiple myeloma, often referred to simply as myeloma, is a complex and frequently misunderstood blood cancer that originates in the bone marrow and affects the immune system. As the second most ...

Johnson & Johnson (J&J) has announced US FDA approval for Tecvayli (teclistamab-cqyv) plus Darzalex Faspro (daratumumab and hyaluronidase-fihj) to treat adults with relapsed or refractory multiple ...

Talquetamab delivers high response rates in refractory myeloma; learn how to prevent skin, nail and oral side effects to stay on therapy. As the therapeutic arsenal for relapsed/refractory multiple ...